Marvel Biosciences Receives Notice of Allowance for Australian Patent Application Covering Composition of Matter for its Lead Therapeutic Candidate MB-204
Go back to Marvel Biosciences Receives Notice of Allowance for Australian Patent Application Covering Composition of Matter for its Lead Therapeutic Candidate MB-204| (AMEX: MBCOF) | Delayed: 0.11 -0.01 (8.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.12 | 52 Week High | $ | |||
| Open | $0.11 | 52 Week Low | $ | |||
| Day High | $0.11 | P/E | N/A | |||
| Day Low | $0.11 | EPS | $ | |||
| Volume | 5,000 | |||||
| Marvell Technology Group Ltd (NASDAQ: MRVL) | Delayed: 282.15 -25.71 (8.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $307.86 | 52 Week High | $13.61 | |||
| Open | $278.82 | 52 Week Low | $7.40 | |||
| Day High | $290.95 | P/E | 440.86 | |||
| Day Low | $277.20 | EPS | $0.64 | |||
| Volume | 22,172,819 | |||||
